ASX - By Stock
CU6
Re:
CU6 - Media and Industry News
ma420
209
84K
20
21/05/24
21/05/24
ASX - By Stock
Comments Created with Sketch. 209
Views Created with Sketch. 84K
Likes Created with Sketch. 20
ASX - By Stock
CU6
Re:
CU6 - Media and Industry News
ma420
209
84K
8
21/05/24
21/05/24
ASX - By Stock
Comments Created with Sketch. 209
Views Created with Sketch. 84K
Likes Created with Sketch. 8
ASX - By Stock
CU6
Re:
Research/Valuation
ma420
527
175K
3
21/05/24
21/05/24
ASX - By Stock
Comments Created with Sketch. 527
Views Created with Sketch. 175K
Likes Created with Sketch. 3
ASX - By Stock
CU6
Re:
Research/Valuation
ma420
527
175K
9
21/05/24
21/05/24
ASX - By Stock
Comments Created with Sketch. 527
Views Created with Sketch. 175K
Likes Created with Sketch. 9
ASX - By Stock
RAC
Re:
Michael Kelso etc
ma420
12
3.6K
1
20/05/24
20/05/24
ASX - By Stock
Comments Created with Sketch. 12
Views Created with Sketch. 3.6K
Likes Created with Sketch. 1
ASX - By Stock
RAC Biotech
Re:
Dr Tillett - The Accidental Biotech CEO
ma420
7
3.0K
1
20/05/24
20/05/24
ASX - By Stock
Comments Created with Sketch. 7
Views Created with Sketch. 3.0K
Likes Created with Sketch. 1
ASX - By Stock
RAC Biotech
Re:
Dr Tillett - The Accidental Biotech CEO
ma420
7
3.0K
13
20/05/24
20/05/24
ASX - By Stock
Comments Created with Sketch. 7
Views Created with Sketch. 3.0K
Likes Created with Sketch. 13
ASX - By Stock
RAC Biotech
Re:
RAC - Charts & Price Action
ma420
21K
7.2M
26
20/05/24
20/05/24
ASX - By Stock
Comments Created with Sketch. 21K
Views Created with Sketch. 7.2M
Likes Created with Sketch. 26
ASX - By Stock
RAC
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
ma420
234
61K
14
20/05/24
20/05/24
ASX - By Stock
Comments Created with Sketch. 234
Views Created with Sketch. 61K
Likes Created with Sketch. 14
ASX - By Stock
CU6
Re:
Research/Valuation
ma420
527
175K
16
20/05/24
20/05/24
ASX - By Stock
Comments Created with Sketch. 527
Views Created with Sketch. 175K
Likes Created with Sketch. 16
ASX - By Stock
CU6
Re:
Research/Valuation
ma420
527
175K
12
19/05/24
19/05/24
ASX - By Stock
Comments Created with Sketch. 527
Views Created with Sketch. 175K
Likes Created with Sketch. 12
ASX - By Stock
CU6
Re:
CU6 - Media and Industry News
ma420
209
84K
3
19/05/24
19/05/24
ASX - By Stock
Comments Created with Sketch. 209
Views Created with Sketch. 84K
Likes Created with Sketch. 3
ASX - By Stock
CU6
Re:
CU6 - Media and Industry News
ma420
209
84K
1
19/05/24
19/05/24
ASX - By Stock
Comments Created with Sketch. 209
Views Created with Sketch. 84K
Likes Created with Sketch. 1
ASX - By Stock
RAC
Re:
RAC media coverage
ma420
2.1K
718K
9
17/05/24
17/05/24
ASX - By Stock
Comments Created with Sketch. 2.1K
Views Created with Sketch. 718K
Likes Created with Sketch. 9
ASX - By Stock
CU6
Re:
CU6 - ASX Charts
ma420
536
169K
0
17/05/24
17/05/24
ASX - By Stock
Comments Created with Sketch. 536
Views Created with Sketch. 169K
Likes Created with Sketch. 0
ASX - By Stock
CVB
Re:
CVB Media Links
ma420
9
4.1K
0
17/05/24
17/05/24
ASX - By Stock
Comments Created with Sketch. 9
Views Created with Sketch. 4.1K
Likes Created with Sketch. 0
ASX - By Stock
CU6
Re:
Research/Valuation
ma420
527
175K
16
17/05/24
17/05/24
ASX - By Stock
Comments Created with Sketch. 527
Views Created with Sketch. 175K
Likes Created with Sketch. 16
ASX - By Stock
PAA
Re:
Ann: PharmAust receives Orphan Drug Designation for monepantel
ma420
43
12K
29
17/05/24
17/05/24
ASX - By Stock
Comments Created with Sketch. 43
Views Created with Sketch. 12K
Likes Created with Sketch. 29
ASX - By Stock
PAA
Re:
Ann: PharmAust receives Orphan Drug Designation for monepantel
ma420
43
12K
17
17/05/24
17/05/24
ASX - By Stock
Comments Created with Sketch. 43
Views Created with Sketch. 12K
Likes Created with Sketch. 17
ASX - By Stock
RAC
Re:
Ann: RAC Investor Presentation May 2024
ma420
55
15K
8
16/05/24
16/05/24
ASX - By Stock
Comments Created with Sketch. 55
Views Created with Sketch. 15K
Likes Created with Sketch. 8
ASX - By Stock
RAC Biotech
Re:
RAC - Charts & Price Action
ma420
21K
7.2M
4
16/05/24
16/05/24
ASX - By Stock
Comments Created with Sketch. 21K
Views Created with Sketch. 7.2M
Likes Created with Sketch. 4
ASX - By Stock
RAC
Re:
Ann: RAC Investor Presentation May 2024
ma420
55
15K
1
16/05/24
16/05/24
ASX - By Stock
Comments Created with Sketch. 55
Views Created with Sketch. 15K
Likes Created with Sketch. 1
ASX - By Stock
RAC Biotech
Re:
RAC - Charts & Price Action
ma420
21K
7.2M
1
16/05/24
16/05/24
ASX - By Stock
Comments Created with Sketch. 21K
Views Created with Sketch. 7.2M
Likes Created with Sketch. 1
ASX - By Stock
RAC
Re:
Cardioprotection thread
ma420
573
169K
4
16/05/24
16/05/24
ASX - By Stock
Comments Created with Sketch. 573
Views Created with Sketch. 169K
Likes Created with Sketch. 4
ASX - By Stock
RAC
Re:
Ann: RAC Investor Presentation May 2024
ma420
55
15K
26
16/05/24
16/05/24
ASX - By Stock
Comments Created with Sketch. 55
Views Created with Sketch. 15K
Likes Created with Sketch. 26
ASX - By Stock
RAC
Re:
Ann: RAC Investor Presentation May 2024
ma420
55
15K
7
16/05/24
16/05/24
ASX - By Stock
Comments Created with Sketch. 55
Views Created with Sketch. 15K
Likes Created with Sketch. 7
ASX - By Stock
RAC
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
ma420
104
31K
4
16/05/24
16/05/24
ASX - By Stock
Comments Created with Sketch. 104
Views Created with Sketch. 31K
Likes Created with Sketch. 4
ASX - By Stock
CHM
Re:
Ann: 1st patient dosed in CHM 0201 Vactosertib trial
ma420
16
8.2K
5
16/05/24
16/05/24
ASX - By Stock
Comments Created with Sketch. 16
Views Created with Sketch. 8.2K
Likes Created with Sketch. 5
ASX - By Stock
CU6
Re:
CU6 - ASX Charts
ma420
536
169K
9
16/05/24
16/05/24
ASX - By Stock
Comments Created with Sketch. 536
Views Created with Sketch. 169K
Likes Created with Sketch. 9
ASX - By Stock
RAC
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
ma420
104
31K
2
16/05/24
16/05/24
ASX - By Stock
Comments Created with Sketch. 104
Views Created with Sketch. 31K
Likes Created with Sketch. 2
ASX - By Stock
NEU
Re:
Ann: Investor presentation, 15 May 2024
ma420
34
18K
0
15/05/24
15/05/24
ASX - By Stock
Comments Created with Sketch. 34
Views Created with Sketch. 18K
Likes Created with Sketch. 0
ASX - By Stock
NEU
Re:
Ann: Investor presentation, 15 May 2024
ma420
34
18K
4
15/05/24
15/05/24
ASX - By Stock
Comments Created with Sketch. 34
Views Created with Sketch. 18K
Likes Created with Sketch. 4
ASX - By Stock
NEU
Re:
Ann: Investor presentation, 15 May 2024
ma420
34
18K
1
15/05/24
15/05/24
ASX - By Stock
Comments Created with Sketch. 34
Views Created with Sketch. 18K
Likes Created with Sketch. 1
ASX - By Stock
NEU
Re:
Ann: Investor presentation, 15 May 2024
ma420
34
18K
3
15/05/24
15/05/24
ASX - By Stock
Comments Created with Sketch. 34
Views Created with Sketch. 18K
Likes Created with Sketch. 3
General
RAC
Re:
General Comments / Chat
ma420
11K
3.8M
11
15/05/24
15/05/24
General
Comments Created with Sketch. 11K
Views Created with Sketch. 3.8M
Likes Created with Sketch. 11
General
RAC
Re:
General Comments / Chat
ma420
11K
3.8M
20
15/05/24
15/05/24
General
Comments Created with Sketch. 11K
Views Created with Sketch. 3.8M
Likes Created with Sketch. 20
ASX - By Stock
RAC
Re:
RAC media coverage
ma420
2.1K
718K
24
14/05/24
14/05/24
ASX - By Stock
Comments Created with Sketch. 2.1K
Views Created with Sketch. 718K
Likes Created with Sketch. 24
ASX - By Stock
RAC
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
ma420
104
31K
8
14/05/24
14/05/24
ASX - By Stock
Comments Created with Sketch. 104
Views Created with Sketch. 31K
Likes Created with Sketch. 8
ASX - By Stock
RAC
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
ma420
104
31K
7
14/05/24
14/05/24
ASX - By Stock
Comments Created with Sketch. 104
Views Created with Sketch. 31K
Likes Created with Sketch. 7
ASX - By Stock
RAC
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
ma420
104
31K
11
14/05/24
14/05/24
ASX - By Stock
Comments Created with Sketch. 104
Views Created with Sketch. 31K
Likes Created with Sketch. 11
ASX - By Stock
RAC
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
ma420
104
31K
1
14/05/24
14/05/24
ASX - By Stock
Comments Created with Sketch. 104
Views Created with Sketch. 31K
Likes Created with Sketch. 1
ASX - By Stock
RAC
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
ma420
234
61K
5
14/05/24
14/05/24
ASX - By Stock
Comments Created with Sketch. 234
Views Created with Sketch. 61K
Likes Created with Sketch. 5
ASX - By Stock
RAC
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
ma420
104
31K
6
14/05/24
14/05/24
ASX - By Stock
Comments Created with Sketch. 104
Views Created with Sketch. 31K
Likes Created with Sketch. 6
ASX - By Stock
CU6
Re:
CU6 - ASX Charts
ma420
536
169K
8
14/05/24
14/05/24
ASX - By Stock
Comments Created with Sketch. 536
Views Created with Sketch. 169K
Likes Created with Sketch. 8
ASX - By Stock
RAC
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
ma420
104
31K
5
14/05/24
14/05/24
ASX - By Stock
Comments Created with Sketch. 104
Views Created with Sketch. 31K
Likes Created with Sketch. 5
ASX - By Stock
RAC
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
ma420
104
31K
19
14/05/24
14/05/24
ASX - By Stock
Comments Created with Sketch. 104
Views Created with Sketch. 31K
Likes Created with Sketch. 19
ASX - By Stock
RAC
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
ma420
104
31K
25
14/05/24
14/05/24
ASX - By Stock
Comments Created with Sketch. 104
Views Created with Sketch. 31K
Likes Created with Sketch. 25
ASX - By Stock
RAC
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
ma420
104
31K
49
14/05/24
14/05/24
ASX - By Stock
Comments Created with Sketch. 104
Views Created with Sketch. 31K
Likes Created with Sketch. 49
ASX - By Stock
CU6
Re:
CU6 - Media and Industry News
ma420
209
84K
3
13/05/24
13/05/24
ASX - By Stock
Comments Created with Sketch. 209
Views Created with Sketch. 84K
Likes Created with Sketch. 3
ASX - By Stock
CVB
Re:
CVB Media Links
ma420
9
4.1K
0
13/05/24
13/05/24
ASX - By Stock
Comments Created with Sketch. 9
Views Created with Sketch. 4.1K
Likes Created with Sketch. 0